rs284654
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000709.4(BCKDHA):c.995+49G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.605 in 1,609,446 control chromosomes in the GnomAD database, including 296,993 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.63 ( 30481 hom., cov: 31)
Exomes 𝑓: 0.60 ( 266512 hom. )
Consequence
BCKDHA
NM_000709.4 intron
NM_000709.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.91
Genes affected
BCKDHA (HGNC:986): (branched chain keto acid dehydrogenase E1 subunit alpha) The branched-chain alpha-keto acid (BCAA) dehydrogenase (BCKD) complex is an innter mitochondrial enzyme complex that catalyzes the second major step in the catabolism of the branched-chain amino acids leucine, isoleucine, and valine. The BCKD complex consists of three catalytic components: a heterotetrameric (alpha2-beta2) branched-chain alpha-keto acid decarboxylase (E1), a dihydrolipoyl transacylase (E2), and a dihydrolipoamide dehydrogenase (E3). This gene encodes the alpha subunit of the decarboxylase (E1) component. Mutations in this gene result in maple syrup urine disease, type IA. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 19-41422819-G-A is Benign according to our data. Variant chr19-41422819-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 93387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.717 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.628 AC: 95303AN: 151664Hom.: 30457 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
95303
AN:
151664
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.583 AC: 144063AN: 247068 AF XY: 0.584 show subpopulations
GnomAD2 exomes
AF:
AC:
144063
AN:
247068
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.603 AC: 878385AN: 1457664Hom.: 266512 Cov.: 53 AF XY: 0.602 AC XY: 436531AN XY: 725144 show subpopulations
GnomAD4 exome
AF:
AC:
878385
AN:
1457664
Hom.:
Cov.:
53
AF XY:
AC XY:
436531
AN XY:
725144
Gnomad4 AFR exome
AF:
AC:
24475
AN:
33462
Gnomad4 AMR exome
AF:
AC:
21351
AN:
44630
Gnomad4 ASJ exome
AF:
AC:
16237
AN:
26104
Gnomad4 EAS exome
AF:
AC:
18207
AN:
39660
Gnomad4 SAS exome
AF:
AC:
50173
AN:
86214
Gnomad4 FIN exome
AF:
AC:
33188
AN:
50628
Gnomad4 NFE exome
AF:
AC:
674569
AN:
1110886
Gnomad4 Remaining exome
AF:
AC:
36550
AN:
60314
Heterozygous variant carriers
0
19002
38004
57006
76008
95010
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
18244
36488
54732
72976
91220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.628 AC: 95373AN: 151782Hom.: 30481 Cov.: 31 AF XY: 0.627 AC XY: 46467AN XY: 74118 show subpopulations
GnomAD4 genome
AF:
AC:
95373
AN:
151782
Hom.:
Cov.:
31
AF XY:
AC XY:
46467
AN XY:
74118
Gnomad4 AFR
AF:
AC:
0.724135
AN:
0.724135
Gnomad4 AMR
AF:
AC:
0.548571
AN:
0.548571
Gnomad4 ASJ
AF:
AC:
0.623126
AN:
0.623126
Gnomad4 EAS
AF:
AC:
0.432501
AN:
0.432501
Gnomad4 SAS
AF:
AC:
0.584859
AN:
0.584859
Gnomad4 FIN
AF:
AC:
0.659247
AN:
0.659247
Gnomad4 NFE
AF:
AC:
0.599673
AN:
0.599673
Gnomad4 OTH
AF:
AC:
0.616445
AN:
0.616445
Heterozygous variant carriers
0
1794
3588
5383
7177
8971
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
776
1552
2328
3104
3880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1845
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jan 12, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Maple syrup urine disease Benign:1
Jun 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at